Ƶ

[Skip to Navigation]
Sign In

May 2024 - July 1883

Decade

Year

Issue

January 23/30, 2024, Vol 331, No. 4, Pages 271-368

In This Issue of JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2024;331(4):e2318184. doi:10.1001/jama.2023.18184
Original Investigation

Anxiety and Depression Symptoms After the Dobbs Abortion Decision

Abstract Full Text
has audio
JAMA. 2024;331(4):294-301. doi:10.1001/jama.2023.25599

This retrospective analysis compares symptoms of depression and anxiety before and after the Supreme Court overturned Roe v Wade between residents in states with abortion triggers vs those in states without trigger laws.

Functional Outcomes After Localized Prostate Cancer Treatment

Abstract Full Text
JAMA. 2024;331(4):302-317. doi:10.1001/jama.2023.26491

This observational study uses registry data to compare rates of adverse functional outcomes between specific treatments for localized prostate cancer (radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance for favorable-prognosis disease and radical prostatectomy or external beam radiotherapy with androgen deprivation therapy for unfavorable-prognosis disease).

Cancer Diagnoses After Recent Weight Loss

Abstract Full Text
has active quiz
JAMA. 2024;331(4):318-328. doi:10.1001/jama.2023.25869

This study compares the rates of subsequent cancer diagnoses over 12 months among health professionals in the Nurses’ Health Study and the Health Professionals Follow-Up Study with weight loss during the prior 2 years compared with those without recent weight loss.

Research Letter

Lifting of Embargoes to Data Sharing in Clinical Trials Published in Top Medical Journals

Abstract Full Text
JAMA. 2024;331(4):354-355. doi:10.1001/jama.2023.25394

This study assesses data sharing status and lifting of embargoes in randomized clinical trials from top medical journals 3 to 5 years after publication.

Biologic Patent Thickets and Terminal Disclaimers

Abstract Full Text
JAMA. 2024;331(4):355-357. doi:10.1001/jama.2023.25389

This study analyzes the use and timing of terminal disclaimers in all biologic patents involved in litigation from 2010 to 2023.

US Preventive Services Task Force

Recommendation Statement

Screening for Speech and Language Delay and Disorders in Children: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2024;331(4):329-334. doi:10.1001/jama.2023.26952

This 2023 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children 5 years or younger without signs or symptoms (I statement).

Evidence Report

Screening for Speech and Language Delay and Disorders in Children 5 Years or Younger: Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has active quiz has audio
JAMA. 2024;331(4):335-351. doi:10.1001/jama.2023.24647

This systematic review to support a 2024 US Preventive Services Task Force Recommendation Statement summarizes published evidence on the benefits and harms of screening for speech and language delay and disorders in children 5 years or younger.

Viewpoint

Is Vaccination Approaching a Dangerous Tipping Point?

Abstract Full Text
JAMA. 2024;331(4):283-284. doi:10.1001/jama.2023.27685

This Viewpoint discusses declining vaccination rates in the US, specifically against COVID-19, and the ways in which clinicians and the Food and Drug Administration can counter the current large volume of vaccine misinformation.

Why Stating Hypotheses in Grant Applications Is Unnecessary

Abstract Full Text
JAMA. 2024;331(4):285-286. doi:10.1001/jama.2023.27163

This Viewpoint argues that a hypothesis-centric approach to writing grant applications is problematic and instead suggests that funding applications should be evaluated by their relevance and methodological quality rather than by qualitative assertions before the study is conducted.

A Piece of My Mind

Setting Intentions

Abstract Full Text
JAMA. 2024;331(4):287-288. doi:10.1001/jama.2023.26823

In this narrative medicine essay, an oncologist ruminates over a chemotherapy consent form about the goals of therapy for a young adult whose body is filled with an aggressive cancer most commonly seen in children.

Editorial

Mental Health Symptoms When Abortion Access Is Restricted

Abstract Full Text
has audio
JAMA. 2024;331(4):289-291. doi:10.1001/jama.2023.26816

Recommendations for Speech and Language Screenings: Lack of Evidence Should Not Endorse Lack of Action

Abstract Full Text
has audio
JAMA. 2024;331(4):292-293. doi:10.1001/jama.2023.26817
JAMA Clinical Guidelines Synopsis

Diagnosis and Management of Aortic Diseases

Abstract Full Text
has active quiz
JAMA. 2024;331(4):352-353. doi:10.1001/jama.2023.23668

This JAMA Clinical Guidelines Synopsis summarizes the 2022 American College of Cardiology/American Heart Association guidelines for diagnosis and management of aortic disease.

Editor's Note

Healing Through Poetry’s Voice

Abstract Full Text
free access
JAMA. 2024;331(4):364. doi:10.1001/jama.2023.24166
Medical News & Perspectives

AI in Medicine

How to Navigate the Pitfalls of AI Hype in Health Care

Abstract Full Text
has multimedia has audio
JAMA. 2024;331(4):273-276. doi:10.1001/jama.2023.23330

In this Medical News article, Arvind Narayanan, PhD, a professor of computer science at Princeton University, discusses the benefits of using artificial intelligence in research and clinical settings while remaining cautious of hype, biases, and data privacy issues.

What to Know About PREVENT, the AHA’s New Cardiovascular Disease Risk Calculator

Abstract Full Text
has audio
JAMA. 2024;331(4):277-279. doi:10.1001/jama.2023.25115

This Medical News article discusses the American Heart Association’s new cardiovascular disease risk calculator, called PREVENT.

Medical News in Brief

More Virulent Mpox Clade Can Be Sexually Associated, WHO and CDC Warn

Abstract Full Text
JAMA. 2024;331(4):280. doi:10.1001/jama.2023.26109

“Alarming” Number of Patients Stop Taking Second-Line Diabetes Drugs

Abstract Full Text
JAMA. 2024;331(4):280. doi:10.1001/jama.2023.26110

First Large Study of GLP-1 Receptor Agonists During Pregnancy

Abstract Full Text
JAMA. 2024;331(4):280. doi:10.1001/jama.2023.26112

Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy

Abstract Full Text
JAMA. 2024;331(4):280. doi:10.1001/jama.2023.26113

High-Dose Flu Vaccine May Be More Effective for Midlife Adults

Abstract Full Text
JAMA. 2024;331(4):280-281. doi:10.1001/jama.2023.26114

Tool Could Help Counsel Patients With Liver Disease Who Drink Alcohol

Abstract Full Text
JAMA. 2024;331(4):281. doi:10.1001/jama.2023.26115

Most Firearm Deaths in US Children Happen While They Play

Abstract Full Text
JAMA. 2024;331(4):281. doi:10.1001/jama.2023.26116

Hormone Produced by Fetus Tied to Severe Vomiting During Pregnancy

Abstract Full Text
JAMA. 2024;331(4):281. doi:10.1001/jama.2023.26117

Violence Against Partners, Children Tied to Broader Health Problems

Abstract Full Text
JAMA. 2024;331(4):281. doi:10.1001/jama.2023.26118
Poetry and Medicine

Laryngectomy

Abstract Full Text
JAMA. 2024;331(4):364. doi:10.1001/jama.2023.23790
JAMA Revisited

The Conquest of Pellagra

Abstract Full Text
JAMA. 2024;331(4):365. doi:10.1001/jama.2023.18185
JAMA Patient Page

Screening for Speech and Language Problems in Young Children

Abstract Full Text
free access has audio
JAMA. 2024;331(4):368. doi:10.1001/jama.2023.27630

This JAMA Patient Page describes the pros and cons of screening for speech and language problems in children aged 5 years or younger.

Comment & Response

Options for Building a Diverse Health Care Workforce

Abstract Full Text
JAMA. 2024;331(4):357-358. doi:10.1001/jama.2023.23397

Options for Building a Diverse Health Care Workforce—Reply

Abstract Full Text
JAMA. 2024;331(4):358. doi:10.1001/jama.2023.23400

E-Cigarettes and FDA Nicotine Cap

Abstract Full Text
JAMA. 2024;331(4):358-359. doi:10.1001/jama.2023.24521

E-Cigarettes and FDA Nicotine Cap—Reply

Abstract Full Text
JAMA. 2024;331(4):359-360. doi:10.1001/jama.2023.24524

Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Abstract Full Text
JAMA. 2024;331(4):360. doi:10.1001/jama.2023.24527

Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Abstract Full Text
JAMA. 2024;331(4):360-361. doi:10.1001/jama.2023.24530

Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply

Abstract Full Text
JAMA. 2024;331(4):361-362. doi:10.1001/jama.2023.24533

Adherence to CPAP Treatment

Abstract Full Text
JAMA. 2024;331(4):362. doi:10.1001/jama.2023.25020

Adherence to CPAP Treatment—Reply

Abstract Full Text
JAMA. 2024;331(4):362-363. doi:10.1001/jama.2023.25023
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2024;331(4):271-272. doi:10.1001/jama.2023.18183
×